This episode of The ShiftShapers Podcast is called “Target and Tame the Drug Spend Monster” with Pramod John, Founder and CEO at VIVIO Health. They discuss the changing nature of specialty drugs as adjuvant therapies and the skyrocketing costs that come with it.

What You’ll Learn From this Episode:
03:31 – Growth of specialty drugs & adjuvant therapies
06:16 – TNF inhibitors, Humira biosims & AbbVie’s threat to litigate
13:25 – Why do Americans pay more for specialty drugs?
19:29 – Standing up against unfair pricing